Verition Fund Management’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-26,171
Closed -$1.21M 3776
2024
Q4
$1.21M Sell
26,171
-88,607
-77% -$3.75M ﹤0.01% 1924
2024
Q3
$3.48M Sell
114,778
-25,902
-18% -$473K 0.02% 1077
2024
Q2
$2.32M Sell
140,680
-19,975
-12% -$320K 0.01% 1182
2024
Q1
$2.47M Buy
+160,655
New +$2.54M 0.02% 1092

Other funds holding TECX

Verition Fund Management's TECX Position: Q1 2025 in Review

Verition Fund Management sold out of Tectonic Therapeutic (TECX) in Q1 2025, closing a stake of 26,171 shares — an estimated $1.21M sold.

Verition Fund Management first reported a position in TECX in Q1 2024 and held it in 4 quarters. The position peaked at $3.48M in Q3 2024. 78 funds tracked by Wall St. Rank hold TECX as of Q1 2025.

  • Verition Fund Management reported no remaining Tectonic Therapeutic position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 26,171 Tectonic Therapeutic shares in Q1 2025, an estimated $1.21M.
  • Verition Fund Management first reported a position in Tectonic Therapeutic in Q1 2024 and held it in 4 quarters.
  • Verition Fund Management's Tectonic Therapeutic position peaked at $3.48M in Q3 2024.
  • 78 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.